Principles of hemostasis in children: models and maturation

Paediatric Anaesthesia - Tập 21 Số 1 - Trang 3-9 - 2011
Nina A. Guzzetta1, Bruce E. Miller1
1Department of Anesthesiology, Emory University School of Medicine, Children’s Healthcare of Atlanta, Atlanta, Georgia

Tóm tắt

SummaryHemostasis is an active process regulating the formation and dissolution of fibrin clot to preserve vascular integrity. The different phases of hemostasis are coordinated so that effective clotting occurs only at the site of vascular injury while maintaining blood flow in other parts of the circulation. Procoagulant processes culminate in thrombin generation and fibrin clot formation to protect the vasculature against uncontrolled bleeding after injury. Conversely, anticoagulant processes limit clot extension to unaffected portions of the vasculature. Lastly, fibrinolysis is responsible for clot dissolution once tissue repair and regeneration permit the return of normal blood flow. A precise and delicate interplay exists among these processes to ensure normal hemostasis. The hemostatic system is incompletely developed at birth and matures throughout infancy. Both full‐term and preterm neonates are born with low levels of most procoagulant proteins including all the contact activation factors and vitamin K‐dependent factors. Similarly, levels of the major anticoagulant proteins are low at birth. Although often characterized as ‘immature’, the neonatal hemostatic system is nevertheless functionally balanced with no tendency toward coagulopathy or thrombosis. In this article, we will review the current models of hemostasis and the maturation of the hemostatic system. Our goal is to help clinicians gain a better understanding of the actions of procoagulant agents and of the disruptive effects of serious systemic illnesses on the precarious hemostatic balance of infants.

Từ khóa


Tài liệu tham khảo

Brummel‐Ziedins K, 2009, Wintrobe’s Clinical Hematology, 528

10.1161/01.ATV.0000259359.52265.62

Calverley DC, 2009, Wintrobe’s Clinical Hematology, 499

10.1182/blood-2006-12-027698

10.2174/0929867043364603

10.1161/01.ATV.0000031340.68494.34

10.1055/s-0037-1615947

10.1161/01.ATV.0000046238.23903.FC

Hoffman M, 2004, How well do we really understand coagulation?, Issues Hemost Manage, 1, 4

10.1056/NEJMra0801082

Hoffman M, 1998, Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high‐dose activated factor VII, Blood Coagul Fibrinolysis, 9, S61

10.1182/blood.V100.1.148

10.1213/ane.0b013e31819bcc9c

10.1111/j.1365-2796.2004.01444.x

10.1182/blood.V90.3.944

10.1309/D0G0C96V05CJ5B4J

10.1046/j.1537-2995.2002.00017.x

10.1097/01.CCM.0000159087.85970.38

10.1016/j.transproceed.2004.11.067

10.3171/jns.2003.98.3.0611

10.1111/j.1460-9592.2008.02905.x

10.1055/s-2000-8455

10.1046/j.1538-7836.2003.00225.x

10.1182/blood.V99.3.923

10.1001/jama.295.3.293

10.1213/ane.0b013e3181618702

10.1017/S0265021508004675

10.1093/bja/ael191

10.1213/ane.0b013e318165dfbb

10.1016/S1473-0502(02)00029-0

10.1213/ane.0b013e318163fb26

10.1016/S0140-6736(07)61199-4

10.1182/blood.V70.1.165.165

10.1016/S0022-3476(73)80436-6

Andrew M, 1988, Development of the human coagulation system in the healthy preterm infant, Blood, 72, 1651, 10.1182/blood.V72.5.1651.1651

10.1055/s-2003-42584

10.1097/00043426-199021000-00019

10.1203/00006450-199503000-00020

Schmidt B, 1989, α‐2‐Macroglobulin is an important progressive inhibitor of thrombin in neonatal and infant plasma, Thromb Haemost, 62, 1074, 10.1055/s-0038-1647120

10.1203/00006450-199204000-00017

Guzzetta NA, 2006, Clinical measures of heparin’s effect and thrombin inhibitor levels in pediatric patients with congenital heart disease, Anesth Analg, 103, 1131, 10.1213/01.ane.0000247963.40082.8b

10.1055/s-0038-1648990

10.1016/S0022-3476(71)80405-5

10.1111/j.1651-2227.2001.tb02431.x

10.1159/000155613

10.1016/0049-3848(74)90050-4

10.1016/0005-2795(72)90210-3

10.1213/01.ANE.0000134811.27812.F0

10.1002/ajh.2830320407

Parmar N, 2006, The fibrinolytic system in newborns and children, Clin Lab, 52, 115

10.1046/j.1538-7836.2003.00081.x

Thông tin
Thông tin xuất bản

Paediatric Anaesthesia

Tập 21 Số 1

3-9

Thông tin tác giả